Introduction Dyspnoea is an existentially burdensome symptom in patients with advanced and progressive diseases such as cancer, chronic obstructive pulmonary disease (COPD) and advanced heart failure.
In a previous press release dated 15 September 2025 [6], Crosetto had noted: ‘Most grants focus on recruitment and training ($2–5 million over five years). The High-Impact/High-Risk Research Awards ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results